Neutrophil-related targets

Neutrophil-related targets encompass a diverse array of proteins, including receptors, enzymes, and adhesion molecules, that regulate the lifecycle and activity of neutrophils. These cells are the primary responders of the innate immune system, migrating to sites of infection or injury to neutralize pathogens through phagocytosis, the release of reactive oxygen species, and the formation of neutrophil extracellular traps (NETs) (Source: StatPearls, 2023). While essential for host defense, excessive or chronic neutrophil activation contributes to the pathogenesis of various inflammatory and autoimmune disorders, such as chronic obstructive pulmonary disease (COPD), rheumatoid arthritis, and vasculitis (Source: PubMed, PMID: 30104718). Therapeutic intervention in this space typically involves inhibiting specific neutrophil-associated mediators like neutrophil elastase or blocking recruitment via chemokine receptors like CXCR2 (Source: Nature Reviews Drug Discovery, 2017). However, because neutrophils are vital for immunity, pharmacological targeting of these pathways presents significant safety challenges, most notably the risk of severe neutropenia and subsequent life-threatening infections (Source: NIH, 2022).

Other names

Neutrophil targetsNeutrophil-associated proteinsNeutrophil signaling pathways

Inhibition of neutrophil-specific proteases (e.g., elastase), antagonism of chemokine receptors (e.g., CXCR1/2) to prevent recruitment, and modulation of granulocyte colony-stimulating factor (G-CSF) signaling.